Mechanical circulatory support in the form of ventricular assist devices (VADs) in children
has undergone rapid growth in the last decade. With expansion of device options available …

Increasing incidence of end-stage heart failure and limited availability of donor organs have
led to longer waiting times for cardiac transplantation and subsequently increasing mortality …

Background The removal of the HeartWare ventricular assist device (HVAD) due to pump
malfunctions and inferior outcomes compared to HeartMate 3 (HM3) in adults has created a …

Patients with acute or progressive heart failure in the setting of congenital heart disease may
need mechanical circulatory support (MCS) to enhance survival while awaiting cardiac …

The field of pediatric mechanical circulatory support has undergone a significant evolution
with the advent of devices designed for children and the implementation of new strategies …

Ventricular assist devices (VADs) are life-saving options for children with heart failure
unresponsive to medical therapy as a bridge to transplantation or cardiac recovery. We …

Background A continuous-flow “adult” ventricular assist device (VAD) was modified to
support infants and children waiting for heart transplantation. Methods A centrifugal VAD …

The use of ventricular-assist device (VAD) support continues to increase and it is now
considered part of the standard of care for most adult and children with end-stage heart …

The development of adult use right ventricular assist devices (RVADs) and pediatric left
ventricular assist devices (pediatric LVADs) have significantly lagged behind compared to …

Purpose The pediatric population has benefited greatly by the evolution of ventricular assist
devices (VADs) leading to miniaturization. Device design like the HeartWare® VAD allows …